Navitrux (fosaprepitant dimeglumine)
New formulation or manufacturer
- Region
- 🇺🇸 US
- Active substance
- fosaprepitant dimeglumine
- Company
- Avyxa Holdings
- Status
- Approved
- FDA approval
- Wed 24 Jun 2026
- Designations
- New formulation or manufacturer
- Application
- NDA220436
- Official record
- www.accessdata.fda.gov
Regulatory milestones
Wed 24 Jun 2026🇺🇸 FDA approval
FDA approves Navitrux (fosaprepitant dimeglumine): new formulation or manufacturer
Avyxa Holdings; NDA220436; New formulation or manufacturer; powder · source
Follow Navitrux
Get VigiEye Daily: approvals, opinions, safety actions and PDUFA dates every morning.
Information from official EMA, FDA, Federal Register and SEC records. Dates marked company-announced come from the company's own SEC filing; dates marked estimate are calculated, not official. Not investment or medical advice; always confirm on the source.